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Abstract 9 
The variation over time of free Zn2+ ion concentration in stirred dispersions of ZnO 10 
nanoparticles (ZnO NPs) prepared in synthetic saliva at pH 6.80 and 37º C was 11 
followed in situ (without solid-liquid separation step) with the electroanalytical 12 
technique AGNES (Absence of Gradients and Nernstian Equilibrium Stripping). At 13 
these conditions, ZnO NPs are chemically unstable due to their reaction with 14 
phosphates. The initial stage of transformation (around 5-10 h) involves the formation 15 
of a metastable solid (presumably ZnHPO4), which later evolves into the more stable 16 
hopeite phase. The overall decay rate of ZnO NPs is significantly reduced in 17 
comparison with phosphate-free background solutions of the same ionic strength and 18 
pH. The effective equilibrium solubilities of ZnO (0.29 - 0.47 mg·L-1), as well as 19 
conditional excess-ligand stability constants and fractional distributions of soluble Zn 20 
species were determined in absence and presence of organic components. The results 21 
were compared with the conventional ultrafiltration and inductively coupled plasma-22 
mass spectrometry (UF-ICP-MS) methodology. AGNES proves to be advantageous in 23 
terms of speed, reproducibility and access to speciation information. 24 
 25 
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Published in Environ.Sci.&Techn. 53 (2019) 3823-3831
 2/28 
1. Introduction  27 
Zinc oxide nanoparticles (ZnO NPs) are increasingly used in rubber, ceramics, paints 28 
and personal care products such as skin creams and sunscreens.1-3 The use of ZnO 29 
nanomaterials in dentistry has also attracted attention recently, due to their antimicrobial 30 
properties.4,5 Some of the most common uses of ZnO NPs are generally regarded as safe 31 
for dermal application.6,7 However, there are a number of studies reporting toxicological 32 
effects of ZnO NPs that might be relevant for other routes of exposure.8 Quite often the 33 
key role of zinc ions released from NPs in the respective toxicity mechanisms is 34 
acknowledged.9,10 Thus, some concerns are currently being raised about the safety of 35 
these materials with regards to oral exposure, due to their potential application in 36 
toothpastes, foods and food packaging.11,12 As point of entrance to the gastrointestinal 37 
tract, the oral cavity represents a compartment of major interest for studies of risk 38 
assessment of ZnO NPs. Consequently, the knowledge of the fate and behaviour of 39 
these materials in saliva is very relevant. Despite that, and to the best of the authors’ 40 
knowledge, no studies on the dissolution behaviour of ZnO in this biological fluid have 41 
been reported so far. 42 
The investigation of the dissolution of nanomaterials is often complicated by the 43 
necessity of a solid-liquid separation step before elemental analysis. Different 44 
separation techniques have been proposed in the literature for this purpose.13-15 One of 45 
the most common methods is ultrafiltration (UF), which involves the use of 46 
semipermeable filters (typically having pore sizes of 3 kDa) in a centrifugation tube. 47 
The filtrate collected after centrifugation is analysed subsequently by a suitable 48 
technique such as inductively coupled plasma-mass spectrometry (ICP-MS).15,16 Even 49 
though UF is an affordable and robust technique, the use of an additional separation step 50 
in the analysis procedure adds a potential source of contamination and/or loss of 51 
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analyte, and increases the time required for sample pre-treatment, which can be 52 
particularly important if the rate of dissolution is to be tested.  53 
On the other hand, the technique Absence of Gradients and Nernstian Equilibrium 54 
Stripping (AGNES)17,18 has been proposed in recent years as an alternative method for 55 
the study of nanomaterial dissolution. AGNES measures directly free metal ion 56 
concentrations in aqueous (or hydro-alcoholic) solutions or dispersions. The 57 
determinands are amalgam-forming metallic elements such Cd, Pb or In,19 but Zn has 58 
been the most extensively analysed so far.20-28 AGNES has been applied, e.g., to 59 
quantify adsorption of Pb or Cd onto latex29-31 and TiO2 nanoparticles,32,33 to study the 60 
dissolution kinetics and equilibrium solubility of ZnO NPs,34,35 to follow the dissolution 61 
of CdTe/CsS quantum dots,36 to elucidate the role of ZnO NP dissolution in toxicity 62 
tests in vitro 37 and in vivo,38 etc. One specific feature of AGNES is that it measures a 63 
well-defined chemical species (the free hydrated metal cation), in contrast to other 64 
operationally defined techniques (such as UF coupled to elemental analysis) that usually 65 
account for more than one chemical species (free ions plus soluble complexes of 66 
different molecular weights). Even though the total solubility (sum of all dissolved 67 
species of a given element) may be larger than the free ion concentration, especially in 68 
complex mixtures, AGNES still allows the estimation of solubility (in ligand-excess 69 
conditions) via a suitable titration procedure.37 An important advantage of AGNES is 70 
that it can be applied directly to the dispersion without the need of any previous 71 
solid/liquid separation step.14,15 In this way, it allows a good control over the 72 
environmental variables (pH, temperature) as well as a relatively short time of analysis, 73 
which is essential for the measurement of dissolution rates. However, up to date, no 74 
direct experimental comparison between AGNES and other separation/analysis coupled 75 
protocols has been reported. Thus, the aim of this work is to elucidate the dissolution 76 
behaviour of ZnO NPs dispersed in a surrogate medium for human saliva using AGNES 77 
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and to compare the results with the conventional UF-ICP-MS approach. A particular 78 
emphasis will be devoted to the role of phosphate and organic components of saliva on 79 
the dissolution rate of ZnO, the chemical speciation of the dissolved phase and the solid 80 
transformation species that may appear. 81 
2. Materials and Methods  82 
2.1 Materials 83 
ZnO nanoparticles (material code JRCNM01100a, also known as NM110) were 84 
procured from the repository of the Joint Research Centre of the European Commission 85 
(Ispra, Italy), as one of the FP-7 NANoREG panel of representative nanomaterials. A 86 
summary of the physicochemical characterization data is included in the Supporting 87 
Information (SI).  88 
Dissolved Zn solutions were prepared from a 1000 mg·L-1 standard solution (Certipur® 89 
Single-element ICP standard from Merck KGaA, Darmstadt, Germany). The 90 
composition of the synthetic saliva solutions is based on a recent in vitro human 91 
gastrointestinal model,39 according to the recipe listed in Table 1: saliva I (containing 92 
only the inorganic components) and saliva II (with both organic and inorganic 93 
components). All reagents within the synthetic saliva were purchased from Sigma-94 
Aldrich Inc. (St. Louis, MO, USA) except mucin (from Carl Roth Gmbh & Co. KG, 95 
Karlsruhe, Germany). 96 
2.2 Nanomaterial dispersion protocol 97 
The NP dispersions were prepared by dilution from a 2.56 mg·mL-1 stock, which was 98 
obtained following the Standard Dispersion Protocol for ecotoxicological studies from 99 
NANoREG.40 In brief, 25.6 mg of ZnO NPs were dispersed in 10 mL of Milli-Q water 100 
and sonicated at 5% amplitude (9.64±0.48 W), for 16 min with a Branson 250S 101 
sonicator (Thermo Fischer Scientific Inc., Waltham, MA, USA) using a 13 mm tip. The 102 
effectively delivered acoustic power of the probe sonicator was previously calibrated 103 
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following a calorimetric method, and the de-agglomeration performance was validated 104 
with appropriate benchmark materials.40 The hydrodynamic sizes measured by Dynamic 105 
Light Scattering (DLS) are reported in the SI. 106 
2.3 Dissolution Assays 107 
The dissolution experiments were carried out by adding a suitable aliquot of the NP 108 
stock solution to a voltammetric thermostated cell containing the synthetic saliva. 109 
Previously, the background solutions were equilibrated at 37.0±0.1ºC and the desired 110 
pH (6.80±0.10) under a controlled atmosphere of 84±1 % N2 (99.9990% purity) and 111 
16±1 % CO2 (99.995% purity) to remove traces of dissolved O2, as it may interfere with 112 
voltammetric measurements. The gas mixture composition was controlled using two 113 
calibrated glass-tube variable area flowmeters (A6100 Series from ABB Ltd., 114 
Workington, UK) and it was checked with a nondispersive infrared carbon dioxide 115 
sensor (K33 ICB 30% CO2 sensor from CO2Meter, Inc., Ormond Beach, FL, USA). 116 
ZnO solubility is extremely sensitive to temperature and pH. In fact, a pH shift of half 117 
unit leads to a variation of up to 1 order of magnitude in the solubility.34 For this reason, 118 
the dispersions were continuously monitored with a glass electrode attached to an 119 
OrionTM 720A+ pH-meter (from Thermo Fischer Scientific Inc., Waltham, MA, USA). 120 
The constant CO2 partial pressure in the sample cell provided an adequate acid-base 121 
buffering. This buffering method, which was previously used in our laboratory,23,37,41 is 122 
more representative of the environmental conditions in the oral cavity than the additions 123 
of strong acid or base. Indeed, the latter method might alter the composition of the 124 
synthetic saliva solutions or even (in the case of base additions) induce the formation of 125 
a hydrated Zn(OH)2 layer on the NP surface.34 Note that any possible differences in 126 
redox potential between the anoxic conditions in the testing vessel and actual oral cavity 127 
conditions are assumed irrelevant for ZnO dissolution, given the absence of reducing 128 
agents in the saliva recipe.  129 
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Control tests were carried out with dissolved Zn standard solutions instead of ZnO NPs. 130 
Ancillary experiments were also performed in absence of CO2 atmosphere to discard the 131 
possible precipitation of solid carbonates.  132 
Once the equilibrated saliva solutions were spiked with the NP stock solutions, three 133 
alternative routes were followed (as described in the following sections): i) the 134 
concentration of free Zn2+ ions was monitored continuously by AGNES; ii) the 135 
NP/saliva dispersions were sub-sampled into 20 mL Wheaton liquid scintillation glass 136 
vials, which were tightly sealed and incubated separately at 37ºC for 24h, and then 137 
measured by UF-ICP-MS; or iii) 1 mL of NP/saliva dispersion was pipetted into a 10 138 
mm optical quartz cuvette for DLS or UV spectrophotometry measurements. 139 
2.4 Measurement of free Zn2+ concentrations 140 
The concentration of free Zn2+ ions, [Zn2+], was measured directly in the saliva media 141 
by AGNES without any prior solid/liquid separation step. AGNES is a voltammetric 142 
technique entailing two stages: deposition and stripping, for which different procedures 143 
or variants can be used. In AGNES-I, the variant used here,18 the stripping current (I) is 144 
measured at a fixed time after the application of an oxidation potential in the diffusion-145 
limited regime. The current is proportional to the free metal concentration in the bulk 146 
sample. The proportionality constant is the product of a calibration factor (h) and a gain 147 
or pre-concentration factor (Y) that can be adjusted by selecting the applied deposition 148 
potential. The two-potential-pulse mode was used in the deposition stage.42 Other 149 
operational parameters are summarized in the SI. These settings allowed a time lapse 150 
between consecutive measurements of ca. 5 min, which is fast enough to track the 151 
evolution of [Zn2+] during dissolution/transformation of ZnO (see Results section). The 152 
electrochemical measurements were carried out with an Autolab PGSTAT12 153 
potentiostat and a 663VA stand (both from Metrohm AG, Herisau, Switzerland) using a 154 
multimode mercury drop electrode (drop radius of 1.41×10−4 m), an auxiliary glassy 155 
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carbon electrode, and an Ag/AgCl/3 mol·L−1 KCl reference electrode, also from 156 
Metrohm. During the application of AGNES, the N2/CO2 gas mixture flowed 157 
continuously through the headspace of the voltammetric cell.  158 
2.5 Other Experimental Methods 159 
The average hydrodynamic diameters and zeta-potential values were measured by 160 
Dynamic Light Scattering (DLS) using a Zetasizer Nano-ZS (Malvern instruments Ltd., 161 
Worcestershire, UK) with a He-Ne laser of 633 nm wavelength, at an angle of 173°. 162 
The autocorrelation functions were analysed with the standard method of cumulants to 163 
obtain the intensity-weighted particle size distributions. The viscosity of the dispersions 164 
was assumed equal to that of pure water at the same temperature, the refractive index of 165 
ZnO was taken as 2.004,43,44 and the attenuation factor and laser position were set to 166 
automatic. Zeta potentials were measured by Laser Doppler Micro-electrophoresis using 167 
also the Zetasizer Nano-ZS. The electrophoretic mobility measurements were 168 
transformed using Henry's equation under Smoluchowski approximation.45  169 
The characteristic absorption spectra of ZnO NPs in dispersion (with a maximum at 170 
λ=371 nm) was followed by time-resolved UV-vis spectrophotometry using a Lambda 171 
XLS spectrophotometer (from PerkinElmer, Inc., Waltham, MA, USA). This provided a 172 
direct measurement of the rate of transformation of ZnO in saliva.34 173 
The solid-liquid fractionation of the dispersions by ultrafiltration (UF) was carried out 174 
with Amicon® Ultra-15 centrifugal filter units (from Merck KGaA, Darmstadt, 175 
Germany) containing a cellulose membrane of 3 kDa molecular weight cut-off.13 In this 176 
procedure, 10 mL samples were ultra-filtered at a relative centrifugal field (RCF) of 177 
5000g for 15 min. After UF, 2 mL were taken from each filtrate and acidified with 178 
HNO3 for subsequent elemental analysis. Then, the total concentration of dissolved Zn, 179 
, was measured by inductively coupled plasma (ICP-MS) using a 7700 Series 180 
instrument from Agilent Technologies, Inc. (Santa Clara, CA, USA). 181 
cT,Zn
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3. Results and discussion 182 
It has been shown that the equilibrium solubility of ZnO NPs increases as the size of 183 
primary particles becomes smaller due to the effect of interfacial tension, according to 184 
the Ostwald-Freundlich equation.34 Due to its relatively large radius (ca. 74 nm), the 185 
NM110 material is expected to have practically the same solubility as bulk ZnO (see 186 
SI). Indeed, the theoretical value of [Zn2+] in equilibrium with bulk ZnO at 37ºC 187 
dispersed in a non-complexing solution at the same pH (6.8) and ionic strength (0.0586 188 
mol·L-1) as saliva is 1.8×10-3 mol·L-1 (equivalent to 150 mg ZnO·L-1), whereas the 189 
Ostwald-Freundlich prediction for NM110 at the same conditions is 157 mg ZnO·L-1. 190 
Note that, in presence of Zn-complexing ligands (such as those present in saliva) the 191 
solubility of ZnO is even larger, as it comprises the sum of all dissolved species of Zn. 192 
However, speciation calculations with the program Visual MINTEQ46 for the specific 193 
composition of saliva I (the organic components of saliva II are not included in the 194 
standard thermodynamic database) predict oversaturation of zinc phosphate or 195 
carbonate salts already at much lower Zn concentrations (as will be discussed later). 196 
Therefore, the first goal was to investigate the time variation of the free Zn2+ 197 
concentration in the dispersions after the addition of increasing amounts of ZnO NPs to 198 
either saliva I or saliva II. The comparison between both media allows us to estimate the 199 
chemical speciation of the dissolved phase and, in particular, the role of the organic 200 
components on the solubility. The following subsections summarize the observed 201 
behaviour of the dispersions regarding their aggregation and dissolution. In the latter 202 
case, we discuss separately the results obtained below and above saturation conditions. 203 
3.1 Stability of ZnO dispersions 204 
The initial hydrodynamic diameters of ZnO NPs measured by DLS in saliva at a total 205 
Zn concentration of 10-3 mol·L-1 (231.2±3.2 nm) were very similar to the stock solution 206 
(see SI) and remained constant during the first 3 hours of the experiments. The zeta 207 
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potential of ZnO particles in the saliva was -35.9±1 mV, whereas a value of 9.7±1.5 mV 208 
was measured in a KCl solution at the same ionic strength (and fast aggregation was 209 
observed within 30 minutes). These results suggest that phosphate is adsorbed on the 210 
surface of NPs at the initial stages,47 which stabilizes the dispersions against 211 
aggregation through an electrostatic mechanism. This fact would be relevant for the 212 
chemical stability of the NPs, since small particle size distributions lead to large 213 
effective surface areas and, consequently, fast rates of transformation of the ZnO NPs 214 
either by dissolution34 or by precipitation of inorganic coatings on the particles’ surface. 215 
However, the DLS measurements are not reliable enough to track the corresponding 216 
changes in the average size.  217 
3.2 Undersaturated solutions  218 
Additions of ZnO NPs to saliva I and II below total Zn concentrations of 4-6×10-6 219 
mol·L-1 (0.3-0.5 mg ZnO·L-1) led to a fast and complete dissolution of the NPs. 220 
Consequently, the values of [Zn2+] reached a constant value within a few minutes after 221 
each addition (below the time resolution of AGNES). This high rate of dissolution is 222 
consistent with a reaction-diffusion model reported previously,34 given the small 223 
particle size distribution of the NPs.  224 
The values of [Zn2+] were proportional to the total Zn concentration, [Zn]total, (Fig 1), as 225 
expected for a medium composition containing organic/inorganic ligands in excess with 226 
respect to the metal. Indeed, the mass balance of Zn prescribes: 227 
(1) 228 
cT,Zn = Zn
2+⎡⎣ ⎤⎦ + ZnHPO4,aq⎡⎣ ⎤⎦ + ZnHCO3
+⎡⎣ ⎤⎦ + ZnSO4,aq⎡⎣ ⎤⎦ + ZnCO3,aq⎡⎣ ⎤⎦ + ZnL⎡⎣ ⎤⎦ + ...=
= Zn2+⎡⎣ ⎤⎦ 1+ ′KZnHPO4,aq + ′KZnHCO3+ + ′KZnSO4,aq + ′KZnCO3,aq + ′KZnL + ....{ } =
= Zn2+⎡⎣ ⎤⎦ 1+ ′Kinorg + ′Korg{ } =
= Zn2+⎡⎣ ⎤⎦ 1+ ′Kmedium{ }
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Where  is the total concentration of dissolved Zn (equal to [Zn]total only in the case 229 
of complete dissolution such as this), and Zn2+, , , , 230 
 are the major inorganic dissolved species of Zn (according to Visual 231 
MINTEQ). L represents a generic organic ligand, and  indicates the conditional 232 
stability constant for the formation of species j (i.e., the stability constant times the 233 
concentration of free ligand). By definition,  has a constant value under excess of 234 
ligand conditions. In eq. (1),  is the collective conditional stability constant of 235 
the dissolved complexes of Zn, which splits into  and , the collective terms 236 
corresponding to the inorganic and organic complexes. Eq. (1) allows AGNES to 237 
estimate the total solubility of ZnO in saturated dispersions, as will be discussed later. 238 
Let us rearrange eq. (1) into a log scale: 239 
 (2) 240 
This linear relationship was confirmed by AGNES measurements in both saliva I and II 241 
(see Fig 1). As expected, the value of  calculated from experimental data using 242 
eq. (2) depends on the composition of the medium. In the case of saliva I, which has 243 
only inorganic components, the value of the collective stability constant was estimated 244 
as , in agreement with the theoretical value from Visual 245 
MINTEQ, . In the case of saliva II, with both organic and inorganic 246 
complexes, the absolute value of the intercept in eq. (2) is larger (i.e., the plot is shifted 247 
towards lower free Zn2+ concentrations). This leads to a value of 248 
, which, in turn, yields . The latter value 249 
could not be compared with Visual MINTEQ because of the lack of stability constants 250 
in the database for complexes of Zn with ligands such as amylase or urea (although a 251 
cT,Zn
ZnHPO4,aq ZnHCO3
+ ZnSO4,aq
ZnCO3,aq
′K j
′K j
′Kmedium
′Kinorg ′Korg
log Zn2+⎡⎣ ⎤⎦ = logcT,Zn − log 1+ ′Kmedium{ }
′Kmedium
′Ksaliva I = ′Kinorg = 2.2 ± 0.1
′Kinorg,theor . = 1.95
′Ksaliva II = ′Kinorg + ′Korg = 4.1± 0.3 ′Korg = 1.9 ± 0.3
Published in Environ.Sci.&Techn. 53 (2019) 3823-3831
 11/28 
value of  was estimated from dedicated AGNES experiments, see SI). 252 
These results indicate a larger complexation capacity of saliva II (due to the 253 
contribution of organic ligands) leading to lower free concentrations compared with 254 
saliva I at the same total Zn concentrations. 255 
The theoretical distribution of Zn species in the dissolved phase is calculated 256 
straightforwardly from the values of , leading to the following results: approximately 257 
20% of dissolved Zn corresponds to free Zn2+ ions, 43% to inorganic complexes and 258 
37% to organic complexes (11% Zn-urea plus 26% of high molecular weight complexes 259 
like amylase and mucin). Note that this distribution is independent of the total 260 
(dissolved plus particulated) Zn concentration, and it is also expected to hold in 261 
saturated solutions at equilibrium, as long as excess of ligand conditions are fulfilled.  262 
3.3 Saturated solutions  263 
3.3.1 Time evolution of [Zn2+]  264 
Large additions of ZnO NP stock solution to saliva (above 0.5 mg ZnO·L-1) led to a 265 
complex dynamic response of AGNES measurements. The evolution of [Zn2+] with time 266 
showed an initial plateau around [Zn2+]=10-5 mol·L-1 (Fig 2) and remained constant (or 267 
decreased very slowly) over a period of 300 to 600 minutes after the NP spike. Then, it 268 
suddenly dropped down to ca. [Zn2+]=10-6 mol·L-1, and this final value was quite 269 
sensitive to small fluctuations in pH. The length of the initial plateau had a low 270 
reproducibility, without clear correlations with NP concentration, stirring rate, exact pH, 271 
etc. On the contrary, the final stable (equilibrium) value of [Zn2+] was very reproducible 272 
and clearly related with the exact pH of the dispersion. This equilibrium value was also 273 
consistent with the solubility of hopeite (Zn3(PO4)2·4H2O), as supported by Visual 274 
MINTEQ and discussed in next section. The hypothesis of hopeite as the final solid 275 
phase is supported by several studies on the reactivity of ZnO with phosphate,47-51 276 
′KZn-urea ≈ 0.58
′K j
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which report a high sensitivity of the composition and structure of the solid on the 277 
environmental variables like pH.47 278 
Noteworthy, the existence of a metastable regime occurs both in saliva I and II (Fig 2), 279 
and its duration does not seem related with the presence of organic components. This 280 
discards the possibility that the growth of an organic coating on the NP surface caused 281 
the initial quasi-steady state in the [Zn2+] vs. time plots.  282 
The evolution of the concentration of solid ZnO with time was also monitored by UV-283 
vis spectrophotometry in parallel to AGNES measurements (Fig SI-2). The data indicate 284 
that the concentration of ZnO decays very slowly during the first few hours after the NP 285 
addition until it suddenly drops down to zero. These long decay times are consistent 286 
with the length of the plateaus observed in the simultaneous AGNES measurements of 287 
[Zn2+].  Moreover, the complete disappearance of the ZnO absorption band coincides 288 
with the achievement of the equilibrium value of [Zn2+] ruled by the solubility product 289 
of hopeite. An ancillary experiment following the dissolution of ZnO NPs in a KCl 290 
solution (in absence of phosphate) at the same temperature, pH and ionic strength 291 
revealed that the half-life of ZnO in these conditions is around 12 min (see also Fig SI-292 
2), in agreement with previous kinetic studies.34 These findings suggest that the 293 
effective rate of dissolution of ZnO NPs in synthetic saliva is modulated by the presence 294 
of phosphate, which increases the half time by a factor of 25-50. This conclusion is also 295 
supported by the results of other authors,48 who reported a substantial increase in the 296 
dissolution times of ZnO NPs in presence of phosphate, compared with similar solutions 297 
where phosphate was absent. Thus, it can be safely concluded that phosphate hinders 298 
the kinetics of dissolution of ZnO NPs, even though the free Zn2+ concentration is 299 
relatively low due to hopeite precipitation. 300 
The initial plateau in the dynamic evolution of [Zn2+] was also observed in the control 301 
experiments where a dissolved Zn standard was added to the synthetic saliva instead of 302 
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ZnO NPs (see Fig SI-3 and one representative example in Fig 1). Indeed, the titration of 303 
saliva with dissolved Zn also led to metastable regimes of variable duration between 304 
300 and 500 minutes, while free ion concentrations remained around -log [Zn2+]=5.0-305 
5.2 (well below the total Zn concentrations in all cases). During this period, a precipitate 306 
was formed (the solution became slightly cloudy), but it was not possible to isolate it or 307 
characterize it further. This metastable phase cannot be ascribed to Zn carbonate, since 308 
it appears also in those titration experiments where all carbonate species were stripped 309 
off the synthetic saliva by N2 purging (Fig SI-3). Note also that, after the plateau, [Zn2+] 310 
values dropped down quickly to stable values around -log [Zn2+]=5.8-6.0, once again in 311 
agreement with the solubility of Zn3(PO4)2·4H2O as calculated by Visual MINTEQ. 312 
Ancillary AGNES experiments consisting of Zn titrations of synthetic saliva solutions 313 
without phosphates, but equilibrated with respect to the CO2/  system, did not 314 
show indications of precipitation at comparable Zn concentrations (see SI). 315 
Nevertheless, the possibility of co-precipitation of carbonates and phosphates of Zn in 316 
the whole saliva cannot be completely ruled out. 317 
The experimental information gathered is consistent with the following mechanism of 318 
concurrent ZnO dissolution and zinc phosphate precipitation: 319 
  (3) 320 
According to this mechanism, the Zn2+ ions released from ZnO NPs at the earliest 321 
stages would quickly react with the phosphate species in solution to form different 322 
soluble complexes as well as an intermediate solid, which could be ascribed to ZnHPO4. 323 
This intermediate phase, probably of amorphous nature, would precipitate faster than 324 
hopeite despite being less stable.49,51 At the same time, a complex chemical and 325 
structural transformation of the ZnO NP surface might occur involving, e.g. 326 
development of a Zn(OH)2 coating, adsorption of phosphate anions (as suggested by the 327 
HCO3
−
ZnO(s)+saliva
fast⎯ →⎯ PO4
-3-coated ZnO(s)
fast⎯ →⎯
fast⎯ →⎯ Zn+2+HPO4
-2! ZnHPO4(s)
slow⎯ →⎯⎯ Zn3(PO4)2 ⋅4H2O(s)
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zeta potential), OH-/PO43- exchange resulting in the formation of an amorphous zinc 328 
phosphate layer,48 etc. The hypothetical formation of this surface coating on the ZnO 329 
NPs would result in a decreased overall rate of dissolution.47 Accordingly, the value of 330 
[Zn2+] in solution would be effectively buffered by the precipitation of ZnHPO4(s), thus 331 
showing an apparent plateau in the dynamic behaviour. A pseudo-steady state would 332 
settle where the rate of Zn2+ release from ZnO dissolution becomes similar to the rate of 333 
transformation of ZnHPO4(s) into hopeite. When crystallization of hopeite (the rate-334 
limiting step) is completed and all ZnHPO4(s) is exhausted, the value of [Zn2+] in 335 
solution would quickly drop down to the value in equilibrium with Zn3(PO4)2·4H2O(s). 336 
If this mechanism is correct, it would also explain the existence of a plateau during the 337 
titration experiments with dissolved Zn standards. In this case, the steady-state value of 338 
the free Zn2+ concentration would be , assuming conditions 339 
of equilibrium and excess of phosphate species, with  being the solubility 340 
product of ZnHPO4(s) and  the mean ion activity coefficient. An estimate of  341 
at 37ºC was obtained from AGNES experiments, as detailed in the SI. Theoretical 342 
predictions of [Zn2+] in equilibrium with ZnHPO4(s) were calculated with Visual 343 
MINTEQ using this value of . The results are represented as the upper dashed 344 
red line in Fig 1. Note that the line bends upwards slightly at large values of [Zn]total due 345 
to the depletion of ligands (this indicates the upper boundary of ligand excess 346 
conditions). 347 
Finally, the assumption that the overall rate of transformation is limited by the hopeite 348 
crystallization step also explains why the behaviour of the [Zn2+] vs. time curves in the 349 
titrations with NPs and Zn standards are so similar.  350 
Zn2+⎡⎣ ⎤⎦ =
Ksp,ZnHPO4
γ ±
2 HPO4
2-⎡⎣ ⎤⎦
Ksp,ZnHPO4
γ ± Ksp,ZnHPO4
Ksp,ZnHPO4
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3.3.2 [Zn2+] at equilibrium and effective solubility  351 
As mentioned above, the final value of [Zn2+] (after a sufficiently large addition of Zn) 352 
is consistent with the solubility equilibrium of hopeite, the thermodynamically stable 353 
phase. Since there is sufficient excess of phosphates in solution, the law of mass action 354 
constrains [Zn2+] at equilibrium to a constant value that depends on pH, but not on the 355 
total Zn concentration: 356 
 (4) 357 
A value of [Zn2+]eq=1.15×10-6 mol·L-1 (-log[Zn2+]eq=5.94) at pH 6.80 was calculated 358 
using Visual MINTEQ with Davies correction of ion activity coefficients and a 359 
solubility product for hopeite at 37ºC of .52 It must be pointed 360 
out that the standard thermodynamic database of Visual MINTEQ contains only the 361 
value at 25ºC ( ) and does not include an estimate of the enthalpy 362 
of dissolution. Interestingly, hopeite shows a retrograde solubility with temperature like 363 
zincite (ZnO).  364 
Eq. 4 applies whenever the liquid phase is in equilibrium with hopeite, regardless the 365 
presence of any dissolved ligands in solution that might form complexes with Zn, which 366 
would only increase the overall solubility of hopeite, but not affect the value of [Zn2+]. 367 
Therefore, this equation is valid for both saliva I and II. 368 
Eq. 4 is represented as a continuous red line in Fig 1. Experimental AGNES results 369 
obtained in equilibrated dispersions of saliva I and II for [Zn]total>10-4 mol·L-1 are in 370 
excellent agreement with this prediction, with a value of [Zn2+]eq=(1.13±0.08)×10-6 371 
mol·L-1, or -log[Zn2+]eq=5.95±0.03. As already mentioned, the titrations performed with 372 
Zn standard (instead of ZnO NPs) yielded similar results. It must be noted that for Zn 373 
additions in the low range of oversaturation conditions, i.e.: 10-5 mol·L-1<[Zn]total<10-4 374 
Zn2+⎡⎣ ⎤⎦eq =
Ksp,hopeite
γ ±
5 PO4
3−⎡⎣ ⎤⎦
2
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
1
3
− logKsp,hopeite,37ºC = 35.74
− logKsp,hopeite,25ºC = 35.42
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mol·L-1, the metastable regime did not evolve towards the hopeite equilibrium within 375 
the timespan of the experiments (Fig 1), due to the relatively small value of the 376 
oversaturation index. 377 
Finally, we define the effective (or apparent) solubility of ZnO NPs in saliva, s, as the 378 
maximum concentration of ZnO that can be dissolved right before the thermodynamic 379 
saturation of hopeite is achieved (which is, in fact, equivalent to the solubility of hopeite 380 
in the medium). This value can be calculated, for each saliva composition, from the 381 
intersection of eq. 2 (the value of [Zn2+] corresponding to full dissolution of ZnO) and 382 
eq. 4 (the value of [Zn2+]eq in equilibrium with hopeite): 383 
 (5) 384 
Where depends on the sample composition. This procedure yielded 385 
s=(3.6±0.3)×10-6 mol·L-1 (0.29 mg ZnO·L-1) and s=(5.7±0.8)×10-6 mol·L-1 (0.47 mg 386 
ZnO·L-1) for saliva I and II, respectively. As expected from the contribution of the 387 
organic ligands, the solubility of ZnO NPs is larger in the latter case. 388 
3.4 Comparison of UF-ICP-MS and AGNES  389 
The results of the dissolution assays measured by UF-ICP-MS are shown in Fig. 3, 390 
where the total dissolved concentration of Zn in the filtrate (cT,Zn) is plotted as a 391 
function of [Zn]total. Two main sources of experimental uncertainty were identified. 392 
First, there was some loss of analyte in the undersaturated solutions due to adsorption of 393 
Zn species on the UF membranes. The effective recovery in UF was quantified, from 394 
filtration tests with Zn standards, as 70% (mean value) of the total dissolved Zn, without 395 
significant differences between saliva I and II. In the latter case, the loss of analyte 396 
might also be due to the complexation of Zn to large molecular weight organic ligands 397 
(which should be retained in the filters). The uncertainty of the experimental data, 398 
however, does not allow discriminating between both fractions (metal directly adsorbed 399 
s = Zn2+⎡⎣ ⎤⎦eq 1+ ′Kmedium{ }
′Kmedium
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on the membrane and metal retained as large organic molecules). Second, and more 400 
importantly, the small volume of N2/CO2 mixture in the headspace of the sample vials 401 
was not enough to buffer pH properly during incubation, especially at the highest NP 402 
doses. Therefore, the final pH values measured after 24 h, right before centrifugation, 403 
were shifted to the alkaline region by 0.2-1.2 units due to the release of OH- ions during 404 
the dissolution of ZnO. Therefore, the following approximate theoretical correction is 405 
proposed for those samples above the saturation point of hopeite: 406 
 (6) 407 
Where pHexp is the value measured in each vial after incubation, and spHi is the 408 
theoretical concentration of dissolved Zn species in equilibrium with hopeite in saliva at 409 
37ºC and pH i, calculated with Visual MINTEQ. Since only the inorganic components 410 
are included in the standard thermodynamic database, a value of  was 411 
included in the calculations for saliva II as the conditional formation constant of Zn-412 
urea complexes, which were the only organic Zn species theoretically able to pass 413 
through the 3kDa filters. 414 
The corrected UF-ICP-MS results are plotted in Fig. 3 (lower panel) together with the 415 
effective solubilities in saliva I and II (blue and green horizontal lines, respectively) 416 
calculated from AGNES results using eq. (5). The theoretical correction reduces the 417 
experimental uncertainty and improves significantly the agreement between UF-ICP-418 
MS and AGNES, especially in the absence of organic components (saliva I). In saliva 419 
II, however, the UF results overestimate the solubility value obtained with AGNES. 420 
This is particularly remarkable, given that UF should remove the organic complexes of 421 
large molecular weight, which represent a significant fraction of the dissolved Zn. This 422 
overestimation might be due to an excessive correction of the pH shifts or to further 423 
changes in environmental conditions during centrifugation. In any case, the modest 424 
cT,Zn( )UF-ICP-MS
pH6.8
= cT,Zn( )UF-ICP-MS
pH exp
× s
pH 6.8
spH exp
′KZn urea = 0.58
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accuracy of the UF-ICP-MS data of saliva II does not enable an indirect estimation of 425 
the fraction of high molecular weight organic complexes of Zn. 426 
4. Relevance for nanosafety assessment  427 
There are currently no regulatory guidelines for bioavailability and zinc release from 428 
nanomaterials to serve as a comparison for this work, but some useful insights can be 429 
extracted nonetheless. The fact that small concentrations of NM110 dissolve completely 430 
in the timescale of a few minutes, suggests that oral exposure to ZnO NPs might be 431 
assimilated to the case of conventional (non-nano) soluble Zn species at low doses. 432 
Additionally, chemical speciation of the dissolved phase (20% of Zn in the form of free 433 
ions) points to a relatively large bioavailability to the oral cavity microbiota. At high 434 
ZnO concentrations, the dissolution is hindered by the formation of intermediate 435 
metastable solid phases, while the whole transformation into hopeite takes place within 436 
5-8 hours under vigorous stirring. This slow kinetics indicates that metastable and 437 
partially phosphate-converted solid nanoparticles might be transported through the 438 
upper gastrointestinal tract after ingestion. Even though ZnO and its phosphate-439 
transformation products are expected to completely dissolve in the low pH environment 440 
of the stomach,11 the mucus and epithelial tissue of the oesophagus would still be 441 
exposed to them.53 This supports the need for further risk assessment studies that take 442 
into account the aging processes of ingested ZnO particles during transit throughout the 443 
upper digestive tract.  444 
The extrapolation of these results to the evaluation of fate after oral exposure in real 445 
conditions should be considered with caution. Firstly, the NM110 material chosen for 446 
this study, although a representative model material for the testing of regulatory-447 
relevant endpoints,1 is not specifically intended for oral intake. The general findings 448 
presented here should be further checked with ZnO nanomaterials designed for other 449 
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purposes and, in this way, correlations with physicochemical features such as particle 450 
size, presence of synthetic organic coatings, etc. could be established. Secondly, recent 451 
works with Ag NPs have reported that reactivity in natural human saliva samples might 452 
be lower than in synthetic surrogate solutions.54 However, in this respect, the 453 
comparison between saliva I and II shows no indication that organic matter may 454 
decrease the ZnO dissolution rate. Finally, the actual in vivo conditions prevailing in the 455 
oral cavity certainly differ from those adopted in the present in vitro study, in terms of 456 
fluctuations of pH and redox potential, presence of microbial flora and co-ingested 457 
material, hydrodynamics and shear forces, etc.11,12,55 Despite all these shortcomings, this 458 
work represents a proof of concept demonstration of the advantages of electroanalytical 459 
techniques like AGNES for the equilibrium speciation and dynamics of transformation 460 
of nanomaterials in natural fluid solutions, as compared with fractionation/elemental 461 
analysis coupled methods such as UF-ICP-MS. In this respect, AGNES may be valuable 462 
as an analytical tool for regulatory testing procedures. 463 
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Tables 661 
 662 
Table	1:	Composition	of	the	synthetic	saliva	used	in	the	experiments.39	This	663 
recipe	was	used	to	prepare	two	different	synthetic	solutions:	saliva	I	(containing	only	664 
the	inorganic	components),	and	saliva	II	(containing	both	inorganic	and	organic	665 
components).	666 
 667 
Inorganic components 
(Saliva I and II) 
Organic components 
(Saliva II) 
         896 mg·L-1 KCl          200 mg·L-1 urea 
         200 mg·L-1 KSCN          290 mg·L-1 amylase a 
         1021 mg·L-1 NaH2PO4.H2O          15 mg·L-1 uric acid 
         570 mg·L-1 Na2SO4          25 mg·L-1 mucin b 
         298 mg·L-1 NaCl  
         1694 mg·L-1 NaHCO3  
pH = 6.80 ± 0.10, I = 0.0586 mol·L-1 c 
a: α-Amylase from Bacillus sp. Type II-A, lyophilized powder from Sigma-Aldrich, 50-55 kDa mol. wt. 668 
b: Mucin 75-95 %, for biochemistry, isolated from porcine stomach lining, from Carl Roth GmbH. 669 
c: ionic strength value calculated with Visual MINTEQ 670 
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Figures 673 
 674 
 675 
Figure 1: Free Zn2+ concentrations in saliva I (green diamonds) and saliva II (blue 676 
circles) measured by AGNES as a function of the total Zn concentration in the 677 
dispersions, [Zn]total. Filled markers represent equilibrium values while open markers 678 
correspond to metastable values. Diamonds and circles: addition of ZnO NPs. Stars: 679 
addition of dissolved Zn standard (control). The arrows connect initial (metastable) and 680 
final (equilibrium) values within the same experiment. The red lines represent the 681 
values of [Zn2+] determined by the solubility of ZnHPO4(s) (dashed line) and hopeite 682 
(solid line), as calculated with Visual MINTEQ. 683 
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 685 
 686 
Figure 2: Representative examples of the evolution of free Zn2+ concentration 687 
(measured by AGNES) vs. time elapsed since the addition of ZnO NPs to saliva I 688 
(green) and saliva II (blue). The values of total Zn concentration, expressed as -689 
log[Zn]total	=pZntotal	(concentrations	in	mol·L-1),	of	each	experiment	are	indicated	in	690 
the	legend.	The	dashed	lines	are	sigmoidal	fits	and	a	guide	to	the	eye.	The	variability	691 
among	curves	is	due	to	small	differences	in	the	experimental	values	of	pZntotal	and	pH.	692 
  693 
0 200 400 600 800 1000 1200 1400
10-6
10-5
pZntotal=3.0
pZntotal=3.5
pZntotal=3.2
pZntotal=3.1
 [Z
n2
+ ] 
(m
ol
·L
-1
)
 
 
time (min)
Published in Environ.Sci.&Techn. 53 (2019) 3823-3831
 28/28 
 694 
Figure 3: Concentration of dissolved zinc species in synthetic saliva I (green diamonds) 695 
and saliva II (blue circles) measured by UF-ICP-MS. Upper panel: raw data (open 696 
markers). Lower panel: data corrected for loss of Zn due to adsorption on the filters, 697 
and for pH changes during incubation using Visual MINTEQ (filled markers). The 698 
reference pH value is 6.8. The red line represents complete dissolution. Horizontal lines 699 
represent the effective solubilities in saliva I (green) and II (blue) according to eq. (5), 700 
as obtained by AGNES. 701 
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